-
1.
公开(公告)号:WO2023012708A1
公开(公告)日:2023-02-09
申请号:PCT/IB2022/057234
申请日:2022-08-04
Applicant: NOVOCURE GMBH
Inventor: WASSERMAN, Yoram , OBUCHOVSKY, Stas , KUPLENNIK, Nataliya , SHAPIRO, David
Abstract: Alternating electric fields (e.g., TTFields) may be applied to a subject's body using one or more electrode assemblies that includes a sheet of graphite, at least one layer of conductive material disposed on the front face of the sheet of graphite, and an electrode element positioned behind the sheet of graphite. The electrode element has a front face disposed in electrical contact with the rear face of the sheet of graphite. The sheet of graphite spreads both heat and current out in directions that are parallel to the front face of the sheet, which eliminates or at least minimizes hot spots on the electrode assembly. This in turn makes it possible to increase the current without exceeding a temperature safety threshold (e.g., 41° C).
-
公开(公告)号:WO2023275804A1
公开(公告)日:2023-01-05
申请号:PCT/IB2022/056081
申请日:2022-06-29
Applicant: NOVOCURE GMBH
Inventor: VOLOSHIN-SELA, Tali , AVIGDOR, Lilach
Abstract: Certain drugs and other molecules cannot ordinarily traverse the blood brain barrier (BBB). However, when alternating electric fields at certain first frequencies (e.g., 100 kHz) are applied to the brain, the BBB becomes permeable to those molecules. Moreover, certain drugs and other molecules cannot ordinarily traverse cell membranes. However, when alternating electric fields at certain second frequencies are applied to the cells (e.g., 150 kHz for uterine sarcoma cells), the cell membranes become permeable to those molecules. To get a certain drug past both the BBB and the relevant cell membranes, the permeability of both of those barriers can be overcome by sequentially (or simultaneously) applying alternating electric fields at both the first frequency and the second frequency.
-
3.
公开(公告)号:WO2022263984A1
公开(公告)日:2022-12-22
申请号:PCT/IB2022/055420
申请日:2022-06-10
Applicant: NOVOCURE GMBH
Inventor: DOYLE, William
Abstract: Methods of treating and preventing cancer are provided. In some instances, the method comprises delivering radioactive particles to an organ of the subject, wherein the organ contains a tumor, applying alternating electric fields to the organ at a frequency of 50 kHz to 10 MHz (e.g., 50 kHz to 1 MHz or 80 to 500 kHz), and administering systemic cancer therapy to the subject.
-
公开(公告)号:WO2022201060A1
公开(公告)日:2022-09-29
申请号:PCT/IB2022/052655
申请日:2022-03-23
Applicant: NOVOCURE GMBH
Inventor: SHAMIR, Reuven Ruby , WASSERMAN, Yoram , BOMZON, Zeev , PELES ZEEVI, Oren , MARCIANO, Tal
Abstract: A method of applying tumor treating fields to a region of interest of a subject's body corresponding to a tumor, the method including: alternately applying to the region of interest a first electric field between a first pair of locations of the subject's body and a second electric field between a second pair of locations of the subject's body; detecting a change in the region of interest of the subject's body; ceasing applying the first and second electric fields; selecting, based on the detected change, a third pair of locations of the subject's body and a fourth pair of locations of the subject's body, the third and fourth pairs of locations being different than the first and second pairs of locations; and alternately applying to the region of interest a third electric field between the third pair of locations and a fourth electric field between the fourth pair of locations.
-
5.
公开(公告)号:WO2022112945A1
公开(公告)日:2022-06-02
申请号:PCT/IB2021/060876
申请日:2021-11-23
Applicant: NOVOCURE GMBH
Inventor: GILADI, Moshe , DOR-ON, Eyal , ZEEVI, Einav , ENGELMAN, Rotem
Abstract: An alternating electric field may be applied to a target region in a living body or to cells in vitro. The alternating electric field is applied during a first interval of time that is at least 1 hour long. The first interval of time includes a plurality of (e.g., 10) non-overlapping sub-intervals of time per hour. In each of the sub-intervals of time, (a) the alternating electric field has a frequency between 50 kHz and 1 MHz (e.g., 50-500 kHz, or 100-300 kHz), (b) the alternating electric field has a respective peak intensity of at least 0.1 V/cm in at least a portion of the target region, and (c) the alternating electric field remains at the respective peak intensity less than 75% the time (e.g., 25% or 33% of the time).
-
公开(公告)号:WO2022058960A1
公开(公告)日:2022-03-24
申请号:PCT/IB2021/058509
申请日:2021-09-17
Applicant: NOVOCURE GMBH
Inventor: VOLOSHIN-SELA, Tali , AVIGDOR, Lilach , PORAT, Yaara , GILADI, Moshe , MUMBLAT, Helena
IPC: A61N1/40
Abstract: Disclosed are methods of inhibiting a coronavirus from infecting or replicating in a cell comprising exposing the cell to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, wherein the frequency and field strength of the alternating electric field inhibits coronavirus infection or replication. Disclosed are methods of reducing coronavirus copy number per cell comprising exposing the cell to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, wherein the frequency and field strength of the alternating electric field reduces coronavirus copy number in the cell. Disclosed are methods of treating a subject infected with coronavirus comprising applying an alternating electric field to a target site of the subject for a period of time, the alternating electric field having a frequency and field strength, wherein the target site comprises one or more coronavirus infected cells.
-
公开(公告)号:WO2021214693A1
公开(公告)日:2021-10-28
申请号:PCT/IB2021/053305
申请日:2021-04-21
Applicant: HAGEMANN, Carsten , LOHR, Mario , KESSLER, Almuth F. , BUREK, Malgorzata , FORSTER, Carola , BRAMI, Catherine , HERSHKOVICH, Hadas Sara , VOLOSHIN-SELA, Tali , NOVOCURE GMBH
Inventor: HAGEMANN, Carsten , LOHR, Mario , KESSLER, Almuth F. , BUREK, Malgorzata , FORSTER, Carola , BRAMI, Catherine , HERSHKOVICH, Hadas Sara , VOLOSHIN-SELA, Tali
IPC: A61N1/32
Abstract: Many drugs and other molecules cannot ordinarily traverse the blood brain barrier (BBB). However, when alternating electric fields at certain optimum frequencies (e.g., 100 kHz) are applied to the brain, the BBB becomes permeable to those molecules. When the alternating electric fields are discontinued, the BBB eventually recovers to its original impermeable state. Subsequently, re-application of alternating electric fields at the optimum frequencies will re-open the BBB. Ordinarily, many frequencies (e.g., 200 kHz) of alternating electric fields are either ineffective or less effective at inducing permeability than the optimum frequencies. But once the BBB has been opened by applying alternating electric fields at the optimum frequencies, alternating electric fields at non-optimum frequencies can maintain the permeability of a previously-opened BBB.
-
8.
公开(公告)号:WO2021116754A2
公开(公告)日:2021-06-17
申请号:PCT/IB2020/001016
申请日:2020-11-30
Applicant: NOVOCURE GMBH
Inventor: HERSHKOVICH, Hadas , VOLOSHIN-SELA, Tali , BOMZON, Ze'ev
IPC: A61N1/40
Abstract: Disclosed are compositions for and methods of altering the electric impedance to an alternating electric field in a target site of a subject. Disclosed are compositions for methods of improving transport of a nanoparticle across a cell membrane of a cell.
-
公开(公告)号:WO2021092402A1
公开(公告)日:2021-05-14
申请号:PCT/US2020/059437
申请日:2020-11-06
Applicant: NOVOCURE GMBH , DESLAURIERS, Richard
Inventor: DESLAURIERS, Richard
Abstract: Improved hydrogel configurations for use with a TTField-generating system is disclosed. Also disclosed are kits containing the improved hydrogel configurations and methods of producing and using the improved hydrogel configurations.
-
公开(公告)号:WO2021050093A1
公开(公告)日:2021-03-18
申请号:PCT/US2019/059650
申请日:2019-11-04
Applicant: NOVOCURE GMBH
Inventor: CHEN, Dongjiang , TRAN, David
IPC: A61K39/395 , A61P35/00 , A61N1/36
Abstract: Viability of cancer cells (e.g., glioblastoma cells) can be reduced by applying an alternating electric field with a frequency between 100 and 500 kHz to the cancer cells for about 3-10 days and administering a checkpoint inhibitor to the cancer cells.
-
-
-
-
-
-
-
-
-